# Soumya Swaminathan: AI can help where specialists are scarce-if efficacy and safety are proven

> Soumya Swaminathan says AI can help where specialists are scarce, with quick wins in X-ray triage and slide reads. Still, demand proof, oversight, and a clear regulatory path.

- Type: AI news
- Page: https://completeaitraining.com/news/soumya-swaminathan-ai-can-help-where-specialists-are-scarce/
- Published: 2026-02-23
- Updated: 2026-02-23
- Author: Jeroen Erne
- Jobs: Healthcare
- Reading time: 2 min

### AI can lift care where specialists are scarce, says Soumya Swaminathan

New Delhi: Former WHO Deputy Director-General Soumya Swaminathan said AI can materially improve healthcare access in places short on specialists, citing India and parts of Africa. Image and pattern recognition-reading X-rays and pathology slides-are the clearest near-term wins, provided models are trained on high-quality, representative datasets.

These tools are already in circulation, she noted, with many more on the way. Her caution to health systems: treat new AI like a new drug or vaccine-prove efficacy and safety before scale, and bring it under a clear regulatory pathway.

#### Where AI helps right now

- Radiology support: triage chest X-rays, flag likely TB or pneumonia, prioritize reads during surges.
- Pathology pre-screening: detect suspicious regions on slides, reduce false negatives, speed up workflows.
- Mental health: assist screening and follow-up using validated tools, with clinician oversight.
- Frontline augmentation: decision support in low-resource settings to standardize basics and escalate the right cases.

#### Clinical standard, not hype

Swaminathan urged formal evaluation before deployment at scale-like trials for drugs and vaccines. That means real-world performance data, safety monitoring, and a defined path to authorization and post-market surveillance.

- Run prospective, clinically relevant studies with blinded comparison to gold-standard reads.
- Report sensitivity/specificity, AUC, NPV/PPV by subgroup (age, sex, comorbidities, device type, site).
- Verify dataset quality and representativeness; document labeling standards and inter-rater agreement.
- Keep a human in the loop, with clear override rules and audit trails.
- Plan for data protection, consent, bias audits, and periodic re-validation after updates.
- Map to a regulatory route and post-market monitoring plan. See WHO's guidance on [regulatory considerations for AI in health](https://www.who.int/publications/i/item/9789240073326?ref=completeaitraining.com).

#### Implementation checklist for hospitals and programs

- Define a narrow, high-value use case with measurable outcomes (e.g., time-to-report cut by 30%, missed findings ↓).
- Assess infrastructure: PACS/LIS integration, device compatibility, data security, offline/edge needs.
- Procure transparently: demand model cards, validation evidence on local populations, and support SLAs.
- Pilot in one unit, measure drift and equity impacts, and compare against current standard of care.
- Train clinicians and technicians; standardize escalation and documentation inside existing workflows.
- Monitor continuously: false positives/negatives, turnaround times, clinician trust, patient outcomes, and costs.

#### India AI Impact Summit 2026: headlines clinicians should note

- Guiding pillars: People, Planet, Progress-human-centric benefits, environmental responsibility, and inclusive growth.
- MANAV Vision announced: Moral and Ethical Systems, Accountable Governance, National Sovereignty, Accessible and Inclusive, Valid and Legitimate.
- Infrastructure: Tata Group and OpenAI to build 100 MW of AI capacity in India, scalable to 1 GW.
- Models: BharatGen Param2 (17B parameters; 22 languages) launched, alongside new LLMs from Sarvam AI.
- Public interest was strong; the India AI Impact Expo was extended and closed on February 21, according to ANI.

Why this matters for healthcare: stronger compute and multilingual models can push validated tools closer to the point of care-especially where specialists are scarce. But adoption must follow clinical evidence, tight integration with PACS/LIS, and ongoing safety checks.

For policy and governance context, see WHO's [ethics and governance of AI for health](https://www.who.int/publications/i/item/9789240029200?ref=completeaitraining.com). For practical training and implementation insights across diagnostics and care pathways, explore [AI for Healthcare](https://completeaitraining.com/tag/healthcare/).

---

This is the Markdown form of https://completeaitraining.com/news/soumya-swaminathan-ai-can-help-where-specialists-are-scarce/. The whole site is mapped at https://completeaitraining.com/llms.txt.
